General InformationModerna is a publicly-traded biotechnology company founded in 2010 and headquartered in Cambridge, MA, with over 1,000 employees focused on mRNA therapeutics and vaccines.
Funding & FinancialsModerna is a public company (NASDAQ: MRNA) with significant market capitalization; it has raised billions in public markets and partnerships rather than traditional venture funding.
Leadership & TeamCEO Stéphane Bancel has led the company since its founding; the company is known for its mRNA platform technology developed by co-founders including Derrick Rossi.
Recent ActivityModerna continues to develop mRNA-based therapeutics beyond COVID-19, including vaccines for influenza, RSV, and various cancer treatments, with several programs in clinical trials.